Analyst
Jefferies
Equibles does not estimate personal net worth.
Michael Sarkone is recorded as Analyst at Jefferies. Michael Sarkone has spoken on 6 earnings calls and 3 other investor events across 5 companies, most recently for Cytosorbents Corp on November 12, 2026. Those appearances were for Henry Schein Inc (HSIC), PROCEPT BioRobotics Corp (PRCT), Lemaitre Vascular Inc (LMAT), Cytosorbents Corp (CTSO) and Axogen, Inc. (AXGN). The companies whose calls Michael Sarkone spoke on are classified in the Healthcare sector.
“What makes our position interesting is that the combination –”
“I guess just to start, you know, you talked about the 20% of the baseline for FY27, and exiting the year, you might be at around 60% of hydros comprised in the installed base.”
“Ron, best of luck in retirement, and Emmanuel, looking forward to working with you. On the call, you mentioned starting to see some pressure in discretionary procedures.”
“I guess, George, just to start, you gave us the update on the quick-stick claim, and we've got this timeline measured in years now. And I guess, can you give us a little more color on how you're thinking about allocating resources to that effort?”
“Just to start, can you give us some background on, you know, how the transaction came to fruition? How long have you been chatting with the BioCircuit people? Just any context around the deal?”
Jefferies
Analyst
Transcript header (unverified)
HSIC
Medical Distribution · Healthcare
Medical Instruments & Supplies · Healthcare
CTSO
Medical Devices · Healthcare
AXGN
Medical Devices · Healthcare
